FENÓMENO DE LÚCIO

Lílian Morais Ferreira; Amanda Pereira Medeiros; Larissa Guerzoni Gasparelo; José Luiz Moller Flôres Soares; Clarice Gabardo Ritter; Tatiana Wittée Neetzow Nunes

doi:10.29021/spdv.73.4.491

Lílian Morais Ferreira Médica Especialista em Medicina Interna/Specialist, Internal Medicine; Hospital Nossa Senhora da Conceição, Porto Alegre, Rio Grande do Sul, Brasil
Amanda Pereira Medeiros Médica Residente de Medicina Interna/Resident, Internal Medicine; Hospital Nossa Senhora da Conceição, Porto Alegre, Rio Grande do Sul, Brasil
Larissa Guerzoni Gasparelo Médica Residente de Medicina Interna/Resident, Internal Medicine; Hospital Nossa Senhora da Conceição, Porto Alegre, Rio Grande do Sul, Brasil
José Luiz Moller Flôres Soares Médico Especialista em Medicina Interna/Specialist, Internal Medicine; Preceptor do Programa de Residência Médica de Medicina Interna/Tutor of the Residence Program in Internal Medicine; Hospital Nossa Senhora da Conceição e do Hospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brasil
Clarice Gabardo Ritter Médica Dermatologista/Dermatologist; Hospital Nossa Senhora da Conceição, Porto Alegre, Rio Grande do Sul, Brasil
Tatiana Wittée Neetzow Nunes Médica Especialista em Patologia/Specialist in Pathology. Coordenadora e Responsável Técnica do Laboratório de Patologia/Head of the Pathology Department; Hospital Nossa Senhora da Conceição, Porto Alegre, Rio Grande do Sul, Brasil

DOI: https://doi.org/10.29021/spdv.73.4.491

Keywords: Leprosy, Lepromatous, Mycobacterium leprae

Abstract

Leprosy is a chronic granulomatous disease caused by the acid-fast bacillus Mycobacterium leprae, which primarily affects the skin and peripheral nerves. Despite implementation of effective multidrug therapy, the new case detection rate remains high. The type of leprosy that patients develop is determined by their cell-mediated immune response to infection. Immunological reactions can occur throughout the disease course and often rapidly accelerate the nerve damage. Lucio phenomenon is a rare and potentially severe type of immunological reaction. We present a 71-year-old male patient diagnosed with lepromatous leprosy and Lucio phenomenon, presenting skin lesions and peripheral neuropathy during six years, that showed resolution of the lesions with appropriate therapy.

Downloads

Download data is not yet available.

References

Rodrigues LC, Lockwood DN. Leprosy now: epidemiology, progress, challenges, and research gaps. Lancet Infect Dis. 2011; 11:464-70.

Kamath S, Vaccaro SA, Rea TH, Ochoa MT. Recognizing and managing the immunologic reactions in leprosy. J Am Acad Dermatol2014; 71:795-803.

Sampaio SAP, Rivitti EA. Dermatologia. 3ª ed. São Paulo: Artes Médicas; 2007.

World Health Organization. WHO Expert Committee on Leprosy. 8th report. Geneva: WHO; 2010.

Kaur C, Thami GP, Mohan H. Lucio phenomenon and Lucio leprosy. Clin Exp Dermatol. 2005; 30:325-27.

Lucio R, Alvarado I. Opusculo Sobre el Mal de San Lazaro o Elefanciasis de los Greigos. México: M. Murguia y Cia;1852.

Latapi F, Chevez Zamoro A. The ‘spotted’ leprosy of Lucio. An introduction to its clinical and histological study. Int J Leprosy. 1948;16: 421.

Nadal R, Framil S. Interpretação das reações sorológicas para diagnóstico e seguimento pós terapêutico da sífilis. Rev Bras Colo-Proctol. 2007; 27:479-82.

David E, Elder MB. Lever's histopathology of the skin. 11ª ed. Philadelphia: Wolters Kluwer; 2015.

Belda Junior W, di Chiacchio N, Criado PR. Tratado de dermatologia. 2ª ed. São Paulo: Atheneu; 2014.

Cecil L, Goldman L, Schafer A. Cecil – Tratado de Medicina Interna. 24ª ed. Rio de Janeiro: Elsevier; 2014.

LUCIO PHENOMENON

Abstract

Downloads

References